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Relevance 
atients with severe mental illness (SMI) are often ill for decades. They have a 
lower quality of life and much higher morbidity and mortality, both in comparison to 
the general population and other patients with mental disorders (1). It is estimated that 
there are around 281,000 patients with SMI in the Netherlands (2). The socio-
economic cost has not been calculated, but it is expected to be high, as patients with 
SMI often need ongoing psychiatric care and rarely have paid employment(3). 
This thesis focuses on patients with SMI and specifically the long-term course, 
recognition, and treatment of movement disorders. Thus enabling us to i) identify 
which factors influence movement disorders over the course of a multidecade illness, 
ii) develop easier and more cost-effective ways of recognizing movement disorders, 
and iii) test if current treatment guidelines are effective in SMI patients. The Curacao 
Extrapyramidal Syndromes Study is well suited for this kind of research as it is the longest 
running study on movement disorders and it includes all patients with SMI on the 
island of Curacao thus limiting bias. 
Studies have shown that over 80% (4,5)of SMI patients have at least one move-
ment disorder and movement disorders are associated with lower quality of life (6), 
poor treatment adherence(7), and increased mortality (8–10). However, there is a pau-
city of research into movement disorders in psychiatric patients in general and move-
ment disorders in SMI patients specifically. Currently, most treatment guidelines men-
tioning movement disorders do not differentiate between SMI and non-SMI. This 
differentiation is important because guidelines are often based on randomized con-
trolled trials (RCTs) performed in populations that are less severely ill, younger, re-
spond better to treatment and have fewer co-morbidities than SMI patients. Severity 
and duration of illness, co-morbidity, age, and duration of illness, are all factors known 
to influence the risk of developing movement disorders and their reaction to treat-
ment. That is why multiple research groups have advocated to test RCT-based treat-
ment recommendations in psychiatry with naturalistic studies (11,12). 
Target groups 
First and foremost this thesis is intended to improve the lives of patients with SMI and to 
inform the professionals who treat them on the prevalence and treatment options of 
movement disorders. This thesis is part of the movement for increased attention for SMI 
patients that started with the 2014 “Over de brug” report by the Kenniscentrum Phrenos. 
SMI patients have been receiving increased attention over the years as it has become clear 
that they are frequently at a disadvantage compared to other members of the population 
(Kenniscentrum Phrenos, ‘Over de brug’ report) both in the socio-economic realm as in 
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the medical realm. For instance, Dutch SMI patients have been shown to face stigmatiza-
tion from health care professionals such as general practitioners and even doctors in train-
ing (13). Also the recent PHAMOUS study showed that patients with SMI have persistent 
low rates of treatment for various metabolic disorders (14).  
This research has already been presented on multiple occasions both nationally and 
internationally and received the 2nd Prize for the best poster presentation from the 
Nederlandse Vereniging voor Psychiatrie (NNVP). It will also be presented to the 
Dutch organization for psychiatric patients and the organization for parents of psychi-
atric patients.  
This thesis is of specific interest for the developers of treatment guidelines that 
cover SMI patients and policy makers connected to SMI patients, both in mental 
health organizations themselves and in the health insurance companies. To this pur-
pose the members of committee that published the Dutch Schizophrenia treatment 
guideline have already been informed of the results of the article that show that the 
effect of switching antipsychotics and dose reduction on movement disorders is differ-
ent in SMI patients compared to other psychiatric patients using antipsychotics.  
Activities/Products 
Wearables and other electronic monitoring devices are becoming more and more 
common in clinical and psychiatric practice. They have several important advantages 
over clinical rating scales and self report scales, firstly they offer an objective measure-
ment thus reducing bias, secondly they can record patients symptoms in their daily life 
where they are most relevant and finally because they involve patients in their own 
treatment. As wearables are becoming cheaper and easier to use it is expected that they 
will become common place in psychiatric treatment 
Originally we investigated blink rate because it would be easy to integrate into an 
app for a mobile phone. However, blink rate alone cannot sufficiently differentiate 
between patients with and without parkinsonism. Combining the blink rate with the 
tasks developed in chapter six (walking, foot stamping, wrist rotation, and bending and 
extending the elbow) could drastically improve the sensitivity and specificity of such an 
app. This app could be developed by a researcher within the MHeNS or by an external 
company.  
On a broader scale the knowledge generated by this thesis has also been used to 
improve national training programs on movement for residents in psychiatry and nurse 
practitioners. Thus improving treatment for patients all over the Netherlands.  
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Innovation 
This thesis is the first to focus on the very long term course of movement disorders in 
psychiatric patients. Whereas previous studies lasted, at most, three to five years this 
thesis has an 18 year follow-up making it unique. This offers new insight into how 
movement orders develop and fluctuate over the decades. Over the course of 10 to 20 
years movement disorders relapse and remit multiple times within a single patient, even 
when no changes in medication are made.  
This thesis, along with other research(15,15–22), challenges the theory that move-
ment disorders in SMI patients are entirely based on medication or, more specifically 
for tardive dyskinesia and parkinsonism, antipsychotic use. This is important because it 
has an enormous impact on how to treat these movement disorders and well as how to 
prevent them. When the assumption is that movement disorders are solely caused by 
antipsychotic medication research and treatment guidelines will focus on stopping 
medication and dose reduction. When movement disorders are considered part of the 
psychiatric disorder their treatment could be either focused on managing the move-
ment disorders themselves or on optimally treating the psychiatric disorder. Either way 
they are much more likely to be effective if the base assumption is correct. This is 
reflected in our findings in chapter two in which recommendations in treatment guide-
lines did not affect movement disorders in patients with SMI as predicted but had no 
effect or in some cases made the movement disorder worse. 
Another way in which this thesis in innovative is the use of instrumental measures 
to diagnose and track movement disorders. As has been mentioned previously instru-
mental measures have important advantages over the clinical rating scales that are 
currently used in both research and clinical practice. They are objective and can be 
used with minimal training in many different settings. They use a continuous as op-
posed to an ordinal scale which means they are easier to interpret and better suited for 
tracking a movement disorder over time. And finally they are more sensitive and can 
be used to identify subtle movement disorders which current rating scales cannot do. 
Schedule & Implementation  
As a continuation of this thesis a new thesis will be started at the end of this year, with 
the aim to develop an integrated set of measures for movement disorders. This set will 
be implemented in the yearly screening and medication review of the SMI patient ward 
of GGz Centraal in Amersfoort.  
Also the new thesis aims to create a longitudinal naturalistic database with data of 
movement disorders, quality of life, psychiatric symptoms, and medication use. This 
data will be made publically available thus enabling both researchers from GGz Cen-
traal as well as researchers from other Dutch institutions to replicate guidelines rec-
ommendations in a naturalistic real world clinical setting. The results from these repli-
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cations for patients with SMI can be integrated into current diagnosis based treatment 
guidelines. Thus enabling treatment guidelines to have recommendations and infor-
mation specific to SMI patients.  
In the long-term treatment guidelines specifically for SMI patients could be devel-
oped, thus making more tailored treatment possible for this patient group. 
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